Autopsy report · NCT02638168

Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With ADHD

“challenge in recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 5 months before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Milton S. Hershey Medical Center

Sponsor type

University, hospital or other

Conditions

Attention Deficit Disorder With Hyperactivity; Behavioral Insomnia of Childhood

Interventions

Immediate Release Methylphenidate; Placebo

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• Evaluation of Nutrition and Metabolism in Breast Cancer Patients
  “Recruitment challenges” (95% match in meaning)
• GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
  “Anticipated recruitment challenges” (90% match in meaning)
• SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer
  “difficulty in recruitment” (88% match in meaning)
• Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
  “Difficulty with recruitment.” (88% match in meaning)
• Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction
  “recruitment difficulty” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.